Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 1
2019 2
2020 2
2021 3
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for athens macmillan
Your search for Athena Macmillan retrieved no results
Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire.
van Leeuwen M, Kieffer JM, Young TE, Annunziata MA, Arndt V, Arraras JI, Autran D, Hani HB, Chakrabarti M, Chinot O, Cho J, da Costa Vieira RA, Darlington AS, Debruyne PR, Dirven L, Doege D, Eller Y, Eichler M, Fridriksdottir N, Gioulbasanis I, Hammerlid E, van Hemelrijck M, Hermann S, Husson O, Jefford M, Johansen C, Kjaer TK, Kontogianni M, Lagergren P, Lidington E, Lisy K, Morag O, Nordin A, Al Omari ASH, Pace A, De Padova S, Petranovia D, Pinto M, Ramage J, Rammant E, Reijneveld J, Serpentini S, Sodergren S, Vassiliou V, Leeuw IV, Vistad I, Young T, Aaronson NK, van de Poll-Franse LV; EORTC QLG. van Leeuwen M, et al. J Cancer Surviv. 2023 Aug;17(4):1111-1130. doi: 10.1007/s11764-021-01160-1. Epub 2022 Jan 27. J Cancer Surviv. 2023. PMID: 35088246 Clinical Trial.
Frequency drift in MR spectroscopy at 3T.
Hui SCN, Mikkelsen M, Zöllner HJ, Ahluwalia V, Alcauter S, Baltusis L, Barany DA, Barlow LR, Becker R, Berman JI, Berrington A, Bhattacharyya PK, Blicher JU, Bogner W, Brown MS, Calhoun VD, Castillo R, Cecil KM, Choi YB, Chu WCW, Clarke WT, Craven AR, Cuypers K, Dacko M, de la Fuente-Sandoval C, Desmond P, Domagalik A, Dumont J, Duncan NW, Dydak U, Dyke K, Edmondson DA, Ende G, Ersland L, Evans CJ, Fermin ASR, Ferretti A, Fillmer A, Gong T, Greenhouse I, Grist JT, Gu M, Harris AD, Hat K, Heba S, Heckova E, Hegarty JP 2nd, Heise KF, Honda S, Jacobson A, Jansen JFA, Jenkins CW, Johnston SJ, Juchem C, Kangarlu A, Kerr AB, Landheer K, Lange T, Lee P, Levendovszky SR, Limperopoulos C, Liu F, Lloyd W, Lythgoe DJ, Machizawa MG, MacMillan EL, Maddock RJ, Manzhurtsev AV, Martinez-Gudino ML, Miller JJ, Mirzakhanian H, Moreno-Ortega M, Mullins PG, Nakajima S, Near J, Noeske R, Nordhøy W, Oeltzschner G, Osorio-Duran R, Otaduy MCG, Pasaye EH, Peeters R, Peltier SJ, Pilatus U, Polomac N, Porges EC, Pradhan S, Prisciandaro JJ, Puts NA, Rae CD, Reyes-Madrigal F, Roberts TPL, Robertson CE, Rosenberg JT, Rotaru DG, O'Gorman Tuura RL, Saleh MG, Sandberg K, Sangill R, Schembri K, Schrantee A, Semenov… See abstract for full author list ➔ Hui SCN, et al. Neuroimage. 2021 Nov 1;241:118430. doi: 10.1016/j.neuroimage.2021.118430. Epub 2021 Jul 24. Neuroimage. 2021. PMID: 34314848 Free PMC article.
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer.
Abraham JE, Pinilla K, Dayimu A, Grybowicz L, Demiris N, Harvey C, Drewett LM, Lucey R, Fulton A, Roberts AN, Worley JR, Chhabra A, Qian W, Vallier AL, Hardy RM, Chan S, Hickish T, Tripathi D, Venkitaraman R, Persic M, Aslam S, Glassman D, Raj S, Borley A, Braybrooke JP, Sutherland S, Staples E, Scott LC, Davies M, Palmer CA, Moody M, Churn MJ, Newby JC, Mukesh MB, Chakrabarti A, Roylance RR, Schouten PC, Levitt NC, McAdam K, Armstrong AC, Copson ER, McMurtry E, Tischkowitz M, Provenzano E, Earl HM. Abraham JE, et al. Nature. 2024 Apr 8. doi: 10.1038/s41586-024-07384-2. Online ahead of print. Nature. 2024. PMID: 38588696
Trend analysis of COVID-19 mis/disinformation narratives-A 3-year study.
Kotseva B, Vianini I, Nikolaidis N, Faggiani N, Potapova K, Gasparro C, Steiner Y, Scornavacche J, Jacquet G, Dragu V, Della Rocca L, Bucci S, Podavini A, Verile M, Macmillan C, Linge JP. Kotseva B, et al. PLoS One. 2023 Nov 17;18(11):e0291423. doi: 10.1371/journal.pone.0291423. eCollection 2023. PLoS One. 2023. PMID: 37976242 Free PMC article.
Using metabolomic profiling to inform use of surrogate species in ecological risk assessment practices.
Seim RF, Glinski DA, Lavelle CM, Awkerman JA, Hemmer BL, Harris P, Raimondo S, Snyder MN, Acrey BW, Purucker ST, MacMillan DK, Brennan AA, Henderson WM. Seim RF, et al. Comp Biochem Physiol Part D Genomics Proteomics. 2022 Mar;41:100947. doi: 10.1016/j.cbd.2021.100947. Epub 2021 Nov 29. Comp Biochem Physiol Part D Genomics Proteomics. 2022. PMID: 34894529 Free PMC article.
Development of online cancer resources to support pre-registration nurses and allied health professionals.
Armoogum J, Taylor V, Cruickshank S, Donaldson J, Wyatt D, Tanay M, Holdsworth F, Cook F, McNamara J, Job C, Rees T, Pope L, Howell C, Sira-Parfitt L, Potter L. Armoogum J, et al. Br J Nurs. 2023 Sep 21;32(17):S14-S18. doi: 10.12968/bjon.2023.32.17.S14. Br J Nurs. 2023. PMID: 37737859
The resultant modules are freely available to all those with an Open Athens account or NHS or UK university email address via the NHS Learning Hub (https://learninghub.nhs.uk)....
The resultant modules are freely available to all those with an Open Athens account or NHS or UK university email address via the NHS …
Enantioselective Organocatalysis-Based Synthesis of 3-Hydroxy Fatty Acids and Fatty γ-Lactones.
Bourboula A, Limnios D, Kokotou MG, Mountanea OG, Kokotos G. Bourboula A, et al. Molecules. 2019 May 31;24(11):2081. doi: 10.3390/molecules24112081. Molecules. 2019. PMID: 31159242 Free PMC article.
Ozonolysis and subsequent oxidation leads to the target products. MacMillan's third generation imidazolidinone organocatalyst has been employed for the epoxide formation, ensuring products in high enantiomeric purity. ...
Ozonolysis and subsequent oxidation leads to the target products. MacMillan's third generation imidazolidinone organocatalyst has bee …
14 results